{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:41:54Z","timestamp":1771015314375,"version":"3.50.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00367","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:25:33Z","timestamp":1554855933000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Inhibitory Effect of KP-A038 on Osteoclastogenesis and Inflammatory Bone Loss Is Associated With Downregulation of Blimp1"],"prefix":"10.3389","volume":"10","author":[{"given":"Hye Jung","family":"Ihn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doohyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Sup","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il Ho","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Chul","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-In","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1172\/JCI35711","article-title":"NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism.","volume":"118","author":"Aliprantis","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/jac\/dkl182","article-title":"Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach.","volume":"58","author":"Banfi","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-0757.2010.00347.x","article-title":"Mechanisms and control of pathologic bone loss in periodontitis.","volume":"2000","author":"Bartold","year":"2010","journal-title":"Periodontology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH645>3.0.CO;2-Q","article-title":"Regulation of the differentiation and function of osteoclasts.","volume":"192","author":"Chambers","year":"2000","journal-title":"J. Pathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/adt.2006.4.387","article-title":"High throughput screening identified a substituted imidazole as a novel RANK pathway-selective osteoclastogenesis inhibitor.","volume":"4","author":"Chen","year":"2006","journal-title":"Assay Drug Dev. Technol."},{"key":"B6","first-page":"1","article-title":"Naturally occurring and synthetic imidazoles: their chemistry and their biological activities.","volume":"13","author":"De Luca","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/chin.199537188","article-title":"Synthesis and antiinflammatory properties of some novel thiazolidinones and imidazolidinones derived from 4-(3-phenyl-4(3H)-quinazolinon-2-yl)-3-thiosemicarbazone.","volume":"50","author":"el-Feky","year":"1995","journal-title":"Pharmazie"},{"key":"B8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4248\/BR201301003","article-title":"Osteoclasts: new insights.","volume":"1","author":"Feng","year":"2013","journal-title":"Bone Res."},{"key":"B9","first-page":"1098","article-title":"New antitumor imidazole derivative, 5-carbamoyl-1H-imidazol-4-yl piperonylate, as an inhibitor of purine synthesis and its activation by adenine phosphoribosyltransferase.","volume":"42","author":"Fukui","year":"1982","journal-title":"Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0090-6980(81)90085-X","article-title":"The effect of imidazole-analogues on bone resorption in vitro: a suggested role for thromboxane A2.","volume":"21","author":"Heersche","year":"1981","journal-title":"Prostaglandins"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142201","article-title":"Inhibitory effects of KP-A159, a thiazolopyridine derivative, on osteoclast differentiation, function, and inflammatory bone loss via suppression of RANKL-induced MAP kinase signaling pathway.","volume":"10","author":"Ihn","year":"","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1177\/1535370215576310","article-title":"The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway.","volume":"240","author":"Ihn","year":"","journal-title":"Exp. Biol. Med."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170159","article-title":"OCLI-023, a novel pyrimidine compound, suppresses osteoclastogenesis in vitro and alveolar bone resorption in vivo.","volume":"12","author":"Ihn","year":"2017","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.taap.2018.06.017","article-title":"A novel benzamide derivative protects ligature-induced alveolar bone erosion by inhibiting NFATc1-mediated osteoclastogenesis.","volume":"355","author":"Ihn","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nat. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.bbrc.2007.06.023","article-title":"Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells.","volume":"360","author":"Islam","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0166-3542(99)00002-9","article-title":"Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H - imidazole on HCMV DNA replication and permissive infection.","volume":"41","author":"Johnson","year":"1999","journal-title":"Antiviral Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1182\/blood-2006-09-048249","article-title":"MafB negatively regulates RANKL-mediated osteoclast differentiation.","volume":"109","author":"Kim","year":"2007","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1691\/ph.2014.3868","article-title":"A derivative of imidazobenzimidazole, ML106, inhibits melanin synthesis via p38 MAPK activation.","volume":"69","author":"Kim","year":"2014","journal-title":"Pharmazie"},{"key":"B20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2147\/CIA.S2046","article-title":"Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women.","volume":"3","author":"Lambrinoudaki","year":"2008","journal-title":"Clin. Interv. Aging"},{"key":"B21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/0022034515618887","article-title":"Regenerative medicine for periodontal and peri-implant diseases.","volume":"95","author":"Larsson","year":"2016","journal-title":"J. Dent. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0006-291X(03)00695-8","article-title":"Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts.","volume":"305","author":"Lee","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJM199502023320506","article-title":"Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis.","volume":"332","author":"Manolagas","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"26475","DOI":"10.1074\/jbc.M313973200","article-title":"Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos.","volume":"279","author":"Matsuo","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/ciia.2007.2.1.55","article-title":"The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis.","volume":"2","author":"Migliaccio","year":"2007","journal-title":"Clin. Interv. Aging"},{"key":"B26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1084\/jem.20091957","article-title":"The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.","volume":"207","author":"Miyauchi","year":"2010","journal-title":"J. Exp. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1128\/MCB.22.4.992-1000.2002","article-title":"Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.","volume":"22","author":"Mizukami","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1073\/pnas.0912779107","article-title":"Blimp1-mediated repression of negative regulators is required for osteoclast differentiation.","volume":"107","author":"Nishikawa","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.4317\/medoral.19094","article-title":"Alendronate-associated osteonecrosis of the jaws: a review of the main topics.","volume":"19","author":"Paiva-Fonseca","year":"2014","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"B30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jbmr.1739","article-title":"Negative regulation of osteoclast precursor differentiation by CD11b and beta2 integrin-B-cell lymphoma 6 signaling.","volume":"28","author":"Park-Min","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0140-6736(05)67728-8","article-title":"Periodontal diseases.","volume":"366","author":"Pihlstrom","year":"2005","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.bor.0000231912.24740.a5","article-title":"Osteoclasts, rheumatoid arthritis, and osteoimmunology.","volume":"18","author":"Sato","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts.","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1749-6632.2011.06283.x","article-title":"The osteoclast and its unique cytoskeleton.","volume":"1240","author":"Teitelbaum","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.bone.2004.04.023","article-title":"Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.","volume":"35","author":"Wada","year":"2004","journal-title":"Bone"},{"key":"B37","doi-asserted-by":"publisher","first-page":"28355","DOI":"10.1074\/jbc.273.43.28355","article-title":"The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.","volume":"273","author":"Wong","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.20050645","article-title":"DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells.","volume":"202","author":"Yagi","year":"2005","journal-title":"J. Exp. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s13770-018-0116-z","article-title":"Remifentanil negatively regulates RANKL-induced osteoclast differentiation and bone resorption by inhibiting c-Fos\/NFATc1 expression.","volume":"15","author":"Yoon","year":"2018","journal-title":"Tissue Eng. Regen. Med."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/ar3379","article-title":"Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors.","volume":"13","author":"Zhao","year":"2011","journal-title":"Arthr. Res. Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/nm.2007","article-title":"Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis.","volume":"15","author":"Zhao","year":"2009","journal-title":"Nat. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00367\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:25:39Z","timestamp":1554855939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00367\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,10]]},"references-count":41,"alternative-id":["10.3389\/fphar.2019.00367"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00367","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,10]]},"article-number":"367"}}